KLOR-CON 8 MEQ TABLET

What it is

KLOR-CON 8 MEQ TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as potassium chloride, under the trade name “KLOR-CON”.

FDA gives its dosage form as tablet, film coated, extended release and its route as oral.

The labeler, the company named on the label, is Upsher-Smith Laboratories, LLC.

FDA lists it under 2 Established Pharmacologic Classes: Osmotic Laxative and Potassium Salt.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes); the FDA directory lists 4 of them.

NADAC classes it under the rate-setting classes B and B-ANDA, depending on the NDC, and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.54 for 30 tablets (30 × $0.11807 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-08-19. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The NADAC of all 5 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-08-19. The file is new; the price is not.

NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $0.10279 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What NADAC measures · Why 30 tablets · NADAC explanation codes · Carried-forward prices

All 5 NDCs

• 00245-0835-15 · Upsher-Smith Laboratories, LLC · $0.11807 per EA · eff. 2026-08-19 filed carried forward
• 00245-5315-01 · Upsher-Smith Laboratories, LLC · $0.11807 per EA · eff. 2026-08-19 filed carried forward
• 00245-5315-11 · Upsher-Smith Laboratories, LLC · $0.11807 per EA · eff. 2026-08-19 filed carried forward
• 00245-5315-15 · Upsher-Smith Laboratories, LLC · $0.11807 per EA · eff. 2026-08-19 filed carried forward
• 00245-5315-89 · not listed as a package in the FDA directory · $0.11807 per EA · eff. 2026-08-19 filed carried forward

Other strengths, forms and brands

14 other products in the NADAC file share the FDA nonproprietary name potassium chloride with KLOR-CON 8 MEQ TABLET.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 5 NDCs’ NADAC prices is $0.11807 per EA filed.

Of the 43 other products in FDA’s Osmotic Laxative class priced per EA, 35 have a higher middle NADAC price and 8 a lower one. The one in the middle is EFFER-K 20 MEQ TABLET EFF, at $0.523 per EA filed (eff. 2026-09-23).

Of the 16 other products in FDA’s Potassium Salt class priced per EA, 13 have a higher middle NADAC price and 3 a lower one. The one in the middle is KLOR-CON M20 TABLET, at $0.14218 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-08-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.